[Anti-angiogenic agents in cancerology: myth or reality?].
Armand
J-P
JP
Département de médecine, institut Gustave Roussy, 39, rue Camille Desmoulins, F94800 Villejuif, France.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D016044:Fusion Proteins, bcr-abl; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors
D000970:Antineoplastic Agents; D011505:Protein-Tyrosine Kinases; D016044:Fusion Proteins, bcr-abl